VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanisms. - Wikidata - awgldk - TriplyDB

VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanisms.

VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanisms.

http://www.wikidata.org/entity/Q34518168

about

Guidelines for Reporting Articles on Psychiatry and Heart rate variability (GRAPH): recommendations to advance research communication.Money in biomedicine: The senator's sleuth Medical ghost-writing Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve Feasibility and Safety of Transcutaneous Vagus Nerve Stimulation Paired with Notched Music Therapy for the Treatment of Chronic Tinnitus.Transcutaneous Vagus Nerve Stimulation (tVNS) does not increase prosocial behavior in Cyberball.Transcutaneous vagus nerve stimulation: retrospective assessment of cardiac safety in a pilot study.Seizure responses and induction of Fos by the NMDA agonist (tetrazol-5-yl)glycine in a genetic model of NMDA receptor hypofunction Cranial Nerves IX, X, XI, and XII.Neuroimmune Interactions in Schizophrenia: Focus on Vagus Nerve Stimulation and Activation of the Alpha-7 Nicotinic Acetylcholine Receptor Neurostimulatory and ablative treatment options in major depressive disorder: a systematic review Psychological factors in asthma Vagal nerve stimulation reverses aberrant dopamine system function in the methylazoxymethanol acetate rodent model of schizophrenia Evolving refractory major depressive disorder diagnostic and treatment paradigms: toward closed-loop therapeutics.Common genes contribute to depressive symptoms and heart rate variability: the Twins Heart Study Of sophists and spin-doctors: industry-sponsored ghostwriting and the crisis of academic medicine.Mortality and suicide risk in treatment-resistant depression: an observational study of the long-term impact of intervention.Transcutaneous vagus nerve stimulation for the treatment of depression: a study protocol for a double blinded randomized clinical trial Major depressive disorder with melancholia displays robust alterations in resting state heart rate and its variability: implications for future morbidity and mortality.Vagus nerve stimulation for the treatment of depression and other neuropsychiatric disorders.Vagal nerve stimulation in prevention and management of coronary heart disease Effects of yoga versus walking on mood, anxiety, and brain GABA levels: a randomized controlled MRS study.A new theoretical approach to the functional meaning of sleep and dreaming in humans based on the maintenance of 'predictive psychic homeostasis'.Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders.Neuromodulation therapies and treatment-resistant depression Neuromodulation for treatment-resistant depression.Value of Functionalized Superparamagnetic Iron Oxide Nanoparticles in the Diagnosis and Treatment of Acute Temporal Lobe Epilepsy on MRI.Effects of electroacupuncture at auricular concha region on the depressive status of unpredictable chronic mild stress rat models.Depression-Related Increases and Decreases in Appetite: Dissociable Patterns of Aberrant Activity in Reward and Interoceptive Neurocircuitry.Effect of transcutaneous auricular vagus nerve stimulation on major depressive disorder: A nonrandomized controlled pilot study.Transcutaneous Vagus Nerve Stimulation Modulates Default Mode Network in Major Depressive Disorder 2-(2'-((dimethylamino)methyl)-4'-(fluoroalkoxy)-phenylthio)benzenamine derivatives as serotonin transporter imaging agents.Vagus Nerve Stimulation Delivered with Motor Training Enhances Recovery of Function after Traumatic Brain Injury.Chronic vagus nerve stimulation for treatment-resistant depression decreases resting ventromedial prefrontal glucose metabolism.Depression: a repair response to stress-induced neuronal microdamage that can grade into a chronic neuroinflammatory condition?Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 4. Neurostimulation Treatments.Vagus Nerve Stimulation Alters Phase Synchrony of the Anterior Cingulate Cortex and Facilitates Decision Making in Rats.Tractography of the brainstem in major depressive disorder using diffusion tensor imaging.Effect of a 12-week yoga therapy program on mental health status in elderly women inmates of a hospice.Early cortical biomarkers of longitudinal transcutaneous vagus nerve stimulation treatment success in depression.

P2860

Q28067996-FBAE9453-40EB-442F-92F2-FA0699B20154 Q28258861-E4CACE00-5BC7-4804-9989-291DB6E0A99D Q28744060-99437D41-9E2B-4CF5-980A-A64A525C7D93 Q29616854-A3383A90-F670-4B82-AFEE-7E1333E1B518 Q30383552-06C53F9F-94F2-46CE-A500-9572E3FB57AA Q30412129-42002E1C-759E-414A-AD16-0D4EF60E6B8C Q30464737-1732CB82-11C4-4677-9816-57F6CC1CB3AD Q30488071-ECE55F00-EFEB-464A-8B19-90F321A26B54 Q33158833-3BE8EF8B-AFB2-4CC6-8E68-988EF3769C28 Q33740560-42274118-E9A0-4957-8198-4701D607EE24 Q33749527-C0293FD4-2FB8-4E8C-9EE7-25AF77B83F87 Q33848593-8E58E050-C3F9-41A2-BCEE-5BB7372ACF25 Q33865310-BE16D701-C64A-4533-869A-BE1A35C79798 Q33980290-84AAEDE7-4C79-4425-A8C8-27F4053229FB Q34001513-22B50E85-CBE6-40C3-AB76-FF34D691A40F Q34165083-1049AEAB-A85A-4BE7-9303-B254F84A5ADC Q34469254-BBC99289-FA8F-417C-9608-605EFCB2564C Q34513303-1BF0A46E-76BB-43EA-A762-154C6320E3D6 Q34579527-7A4E1C15-A571-4899-BDDB-781E5E9AA4C6 Q34594454-31C4F3FA-5435-4218-BF47-EFB5C9D3A94E Q34863015-BFFEF679-65FF-481B-AD53-CE90C2A58765 Q35034526-ED1BF538-00CE-4AD5-AB74-8F3618D5D1A2 Q35836145-F6BA9FB6-2D8F-4E28-B0FC-73398D2B4C09 Q35862776-A3E4A6A6-C57A-47F9-9084-081F191171B5 Q36395636-41141713-7395-45AF-A3E5-17A51BC05E27 Q36422989-559D5F7A-BF71-4C00-969E-C5C9A4452834 Q36564626-3B5EFE34-7C2C-4C1C-9D8F-B9A054674A8D Q36605979-CCF98A1D-35EF-470A-A8C7-0FFFCC68E857 Q36757880-5A1DB701-0AE7-4903-A46A-7695583E2149 Q36790572-8E8ADE09-BF1B-4A50-BEE6-567E037F9871 Q36820077-EF08FF2C-7F62-4B99-9485-7794595040D2 Q36869118-92B9DB55-1F38-41AD-836D-602FFD3C266D Q36882104-3DC920B8-7E52-4DDE-93FB-D34873F3BFB6 Q37012874-5950F5D1-A344-404E-AE8B-E7BB78D6C594 Q37183514-7EDF8143-72CC-47B2-9394-9E3AFAB217BA Q37197224-5FC53EA6-D6C9-49E7-AF88-04F8B95AAE7C Q37330529-C2E6E01E-D968-434F-BCD4-00E28C3C08BD Q37499232-F40958F3-FB00-4E1C-AFDB-DD1C56FC029F Q37579350-C0678584-D632-440B-A1BD-8764A8610131 Q37613837-2DC0285E-AA4B-427A-AA35-A3D3E86929D1

P2860

VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanisms.

http://www.wikidata.org/entity/Q34518168

description

2006 nî lūn-bûn

@nan

2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

name

VNS therapy in treatment-resis ...... ve neurobiological mechanisms.

@ast

VNS therapy in treatment-resis ...... ve neurobiological mechanisms.

@en

VNS therapy in treatment-resis ...... ve neurobiological mechanisms.

@nl

type

label

VNS therapy in treatment-resis ...... ve neurobiological mechanisms.

@ast

VNS therapy in treatment-resis ...... ve neurobiological mechanisms.

@en

VNS therapy in treatment-resis ...... ve neurobiological mechanisms.

@nl

prefLabel

VNS therapy in treatment-resis ...... ve neurobiological mechanisms.

@ast

VNS therapy in treatment-resis ...... ve neurobiological mechanisms.

@en

VNS therapy in treatment-resis ...... ve neurobiological mechanisms.

@nl

P1433

Q34518168-8BEAEBF4-9326-40DD-BF14-4A8A88D66E1A

P1476

Q34518168-728AA535-EFD9-4381-8E9E-C01BD769BD20

P2093

Q34518168-0947FEE0-05EF-4A37-82CE-335A8E6EFCD7

Q34518168-27A03B28-721B-4D64-A9CF-7D9F1AADAF49

Q34518168-53DD175C-F435-437B-A056-B2AC3D61C259

Q34518168-6556DDAD-C836-432A-BCD0-1AA56B755E83

Q34518168-89CE0C1E-6D74-42A5-B8BE-13020DE36FFB

Q34518168-A37C3E59-FC61-49C2-ADCC-5094BE5B9187

Q34518168-AEC19064-F916-4392-B96F-0173862DD6A1

Q34518168-EFAF1912-692E-497C-87A7-BA490AF5BC79

P2860

Q34518168-05A708AB-450A-4AA5-8B66-CB1508042ABB

Q34518168-0AE2F3AF-FDA2-438D-B35C-EC70B5FA1D16

Q34518168-1050AF28-172C-4521-B27E-40490D0BEAC8

Q34518168-11045922-C08E-41EE-9844-AEDD6CC6004D

Q34518168-1ACA11B7-6ACF-4B99-9CD3-90EBEC2A3A28

Q34518168-1FF03BB6-AE3D-48F3-9600-3F0760B521E6

Q34518168-2066EC8C-EC12-43F3-AF10-03CFDDC7575F

Q34518168-219BB3C8-FD57-4A6B-99F0-5F4154FC16A3

Q34518168-23B563A3-BEDB-417B-BAC3-F9458B2D6CF9

Q34518168-28832B57-BC38-4621-B5DB-FAF11354EC7B

P2888

Q34518168-168247FE-1E9F-4A07-8C77-D2DD91A8DCF8

P304

Q34518168-40CC4419-36C9-4926-87E2-742749C75122

P31

Q34518168-32201137-fdee-4b70-beb7-b7328874fd25

Q34518168-FB7B8117-F546-48BF-952F-6AD3B660E6A9

P356

Q34518168-138193DA-1B1C-462F-8E73-1DEB9B8FEDDC

P407

Q34518168-66E69E29-755E-4BEC-8319-B7A2516C2A95

P433

Q34518168-2ACAF9C8-C040-4E46-A65C-12FD6B3CFCD6

P478

Q34518168-561FF5AE-2251-455B-9EC7-470553438F45

P50

Q34518168-FA9E14AE-D5CE-4C56-B25E-B24673AF2674

P577

Q34518168-5CDFBF76-10F2-46D3-A75F-74BEA1BBD1B8

P5875

Q34518168-261400CD-64CC-4C55-B58A-F96EE32D1042

P6179

Q34518168-B552008E-C124-4AA4-85AD-42AD90F12B9A

P698

Q34518168-D946C713-8B3D-4D85-970A-FCA7B708D2D7

P356

P1433

Neuropsychopharmacology

P1476

VNS therapy in treatment-resis ...... ive neurobiological mechanisms

@en

P2093

Alan Frazer

http://www.w3.org/2001/XMLSchema#string

Charles B Nemeroff

http://www.w3.org/2001/XMLSchema#string

Dennis S Charney

http://www.w3.org/2001/XMLSchema#string

Helen S Mayberg

http://www.w3.org/2001/XMLSchema#string

James McNamara

http://www.w3.org/2001/XMLSchema#string

Mark S George

http://www.w3.org/2001/XMLSchema#string

Scott E Krahl

http://www.w3.org/2001/XMLSchema#string

Stephen K Brannan

http://www.w3.org/2001/XMLSchema#string

P2860

How do you feel? Interoception: the sense of the physiological condition of the body

The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)

Deep brain stimulation for treatment-resistant depression

Feasibility of vagus nerve stimulation-synchronized blood oxygenation level-dependent functional MRI.

A review of functional neuroimaging studies of vagus nerve stimulation (VNS).

Brain blood-flow alterations induced by therapeutic vagus nerve stimulation in partial epilepsy: II. prolonged effects at high and low levels of stimulation.

Decreased regional brain metabolism after ect.

Burden of disease--implications for future research.

Vagus nerve stimulation: a new tool for brain research and therapy.

Functional and chemical anatomy of the afferent vagal system.

P2888

P304

1345-1355

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.NPP.1301082

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-04-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7139102

http://www.w3.org/2001/XMLSchema#string

P6179

1013195159

http://www.w3.org/2001/XMLSchema#string

P698

16641939

http://www.w3.org/2001/XMLSchema#string